Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.
Cavelti-Weder C, Babians-Brunner A, Keller C, Stahel MA, Kurz-Levin M, Zayed H, Solinger AM, Mandrup-Poulsen T, Dinarello CA, Donath MY.
Cavelti-Weder C, et al. Among authors: kurz levin m.
Diabetes Care. 2012 Aug;35(8):1654-62. doi: 10.2337/dc11-2219. Epub 2012 Jun 14.
Diabetes Care. 2012.
PMID: 22699287
Free PMC article.
Clinical Trial.